The demand for high-sensitivity diagnostic testing and the rising prevalence of chronic diseases, such as cancer and endocrine disorders, are sustaining the steady expansion of the specialized laboratory testing sector. The Radioimmunoassay Market was valued at USD 618.44 million in 2024 and is projected to reach USD 854.94 million by 2032, growing at a CAGR of...